About this trial
The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers.
The main question it aims to answer is:
"Which reminder method helps participants come to their scheduled smoking cessation clinic appointments most often?" Researchers will compare different appointment reminder methods with standard appointment scheduling to see if they help participants attend their clinic visits more often.
Participants will:
* Receive appointment reminders using different methods * Come to their scheduled visits at a smoking cessation (anti-nicotine) clinic
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years. Confirmed diagnosis of nicotine dependence (F17 according to the International Classification of Diseases, 10th Revision [ICD-10]) and active patient status at the Smoking Cessation Clinic.
Provision of voluntary, written, informed consent to participate in the study and to be contacted by telephone or short text message.
Ability to independently provide information and operate a mobile phone.
At the time of study enrollment, attendance at an initial visit at the clinic.
Disqualifiers
Age < 18 years.
Lack of written, informed consent to participate in the study.
Inability to independently understand the study procedures or provide responses (e.g., due to dementia or a language barrier).
Trial design
Parallel
Treatments tested in this trial
Standard phone call
BehavioralParticipants will receive a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements.
phone call with MINDSPACE elements
BehavioralParticipants will receive a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE framework. Key components of the script include: * Messenger (Sender): Emphasizing that the information comes from the medical team. * Norms (Social Norms): Referring to success statistics for regular visits. * Commitment: Encouraging verbal confirmation of attendance. * Affect (Emotions): Providing short messages reinforcing a sense of support.
Treatment groups
Trial outcomes
Primary outcomes
Patient attendance at scheduled follow-up visit
Primary Outcome: The primary outcome measure is a binary assessment of patient attendance (Present/Absent) at the scheduled second visit, which takes place 2-8 weeks after the initial visit, as determined by the physician's individual assessment. Attendance will be verified on the day of the scheduled visit based on objective data recorded in the "CliniNET" hospital system.
Secondary outcomes
Impact of sociodemographic and clinical factors on patient attendance
Secondary Outcomes: Secondary analyses will include an assessment of the impact of sociodemographic and clinical factors based on tests routinely performed as part of a medical visit (age, sex, level of dependence according to the Fagerström Test for Nicotine Dependence (FTND)).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: